InvestorsHub Logo
Followers 0
Posts 45
Boards Moderated 0
Alias Born 09/14/2017

Re: staccani post# 1546

Wednesday, 10/25/2017 2:23:15 PM

Wednesday, October 25, 2017 2:23:15 PM

Post# of 2099
@staccani I share much of your sentiments. If all goes well, in 5 to 10 years $20B valuation for VBL is plausible imho.

However, I should add that with 3000 ongoing clinical trials in the US alone, the competition in the biotech sector is tremendous.

Given this competition, the pricing for cancer treatments will have to eventually go down. At present time, we are paying astronomic prices for drugs with microscopic benefits. This cannot continue indefinitely. In the future, the balance must change in favor of lower prices and higher benefits.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News